A risk index for pediatric patients undergoing diagnostic imaging with 99mTc-dimercaptosuccinic acid that accounts for body habitus

Published guidelines for administered activity to pediatric patients undergoing diagnostic nuclear medicine imaging are currently obtained through expert consensus of the minimum values as a function of body weight as required to yield diagnostic quality images. We have previously shown that consideration of body habitus is also important in obtaining diagnostic quality images at the lowest administered activity. The objective of this study was to create a series of computational phantoms that realistically portray the anatomy of the pediatric patient population which can be used to develop and validate techniques to minimize radiation dose while maintaining adequate image quality. To achieve this objective, we have defined an imaging risk index that may be used in future studies to develop pediatric patient dosing guidelines. A population of 48 hybrid phantoms consisting of non-uniform B-spline surfaces and polygon meshes was generated. The representative ages included the newborn, 1 year, 5 year, 10 year and 15 year male and female. For each age, the phantoms were modeled at their 10th, 50th, and 90th height percentile each at a constant 50th weight percentile. To test the impact of kidney size, the newborn phantoms were modeled with the following three kidney volumes:  −15%, average, and  +15%. To illustrate the impact of different morphologies on dose optimization, we calculated the effective dose for each phantom using weight-based 99mTc-DMSA activity administration. For a given patient weight, body habitus had a considerable effect on effective dose. Substantial variations were observed in the risk index between the 10th and 90th percentile height phantoms from the 50th percentile phantoms for a given age, with the greatest difference being 18%. There was a dependence found between kidney size and risk of radiation induced kidney cancer, with the highest risk indices observed in newborns with the smallest kidneys. Overall, the phantoms and techniques in this study can be used to provide data to refine dosing guidelines for pediatric nuclear imaging studies while taking into account the effects on both radiation dose and image quality.

[1]  W Bolch,et al.  ICRP Publication 128: Radiation Dose to Patients from Radiopharmaceuticals: a Compendium of Current Information Related to Frequently Used Substances , 2015, Annals of the ICRP.

[2]  C. Clement ICRP’s Second International Symposium , 2015, Annals of the ICRP.

[3]  Kiery A. Braithwaite,et al.  Gender-based differences in pediatric nuclear medicine. , 2014, Seminars in nuclear medicine.

[4]  D. Minařík,et al.  Effective dose to adult patients from 338 radiopharmaceuticals estimated using ICRP biokinetic data, ICRP/ICRU computational reference phantoms and ICRP 2007 tissue weighting factors , 2014, EJNMMI Physics.

[5]  Wesley E Bolch,et al.  The UF/NCI family of hybrid computational phantoms representing the current US population of male and female children, adolescents, and adults—application to CT dosimetry , 2014, Physics in medicine and biology.

[6]  S. Treves,et al.  Pediatric Radiopharmaceutical Administration: Harmonization of the 2007 EANM Paediatric Dosage Card (Version 1.5.2008) and the 2010 North American Consensus guideline , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  M. Charron,et al.  Pediatric nuclear medicine in acute care. , 2013, Seminars in nuclear medicine.

[8]  C. Land,et al.  RadRAT: a radiation risk assessment tool for lifetime cancer risk projection , 2012, Journal of radiological protection : official journal of the Society for Radiological Protection.

[9]  Wesley E. Bolch,et al.  An Approach for Balancing Diagnostic Image Quality with Cancer Risk: Application to Pediatric Diagnostic Imaging of 99mTc-Dimercaptosuccinic Acid , 2011, The Journal of Nuclear Medicine.

[10]  Frederic H. Fahey,et al.  Minimizing and Communicating Radiation Risk in Pediatric Nuclear Medicine , 2011, The Journal of Nuclear Medicine.

[11]  S. Treves,et al.  Pediatric Radiopharmaceutical Administered Doses: 2010 North American Consensus Guidelines , 2011, The Journal of Nuclear Medicine.

[12]  R. Vetter ICRP Publication 103, The Recommendations of the International Commission on Radiological Protection , 2008 .

[13]  Icrp Chapters 3 and 4 , 2007 .

[14]  J. Conway Quo vadis pediatric nuclear medicine. , 2007, Seminars in nuclear medicine.

[15]  E. Hall,et al.  Intensity-modulated radiation therapy, protons, and the risk of second cancers. , 2006, International journal of radiation oncology, biology, physics.

[16]  J. Valentin Basic anatomical and physiological data for use in radiological protection: reference values , 2002, Annals of the ICRP.

[17]  J. Valentin,et al.  Radiation dose to patients from radiopharmaceuticals: (Addendum 2 to ICRP Publication 53) ICRP Publication 80 Approved by the Commission in September 1997 , 1998, Annals of the ICRP.

[18]  M. Lythgoe,et al.  Radiation dosimetry of technetium-99m-DMSA in children. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  Health Risks from Exposure to Low Levels of Ionizing Radiation : BEIR VII Phase 2 4 / 10 / 2011 , 2011 .

[20]  M. Lassmann,et al.  The new EANM paediatric dosage card , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  K Eckerman,et al.  ICRP Publication 107. Nuclear decay data for dosimetric calculations. , 2008, Annals of the ICRP.

[22]  N Shandala,et al.  Scope of radiological protection control measures. , 2007, Annals of the ICRP.

[23]  M. Lassmann,et al.  The new EANM paediatric dosage card , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  H. Alpay,et al.  The Efficacy of Tc99m Dimercaptosuccinic Acid (Tc-DMSA) Scintigraphy and Ultrasonography in Detecting Renal Scars in Children with Primary Vesicoureteral Reflux (VUR) , 2005, International Urology and Nephrology.

[25]  J. Valentin,et al.  Radiation dose to patients from radiopharmaceuticals , 1998 .

[26]  W. Eckelman,et al.  NCRP report no. 93: Ionizing radiation exposure of the population of the United States: National Council on Radiation Protection and Measurements, Bethesda, Maryland (1987). US$15.00 , 1988 .